Your browser doesn't support javascript.
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
Farr, Ryan J; Rootes, Christina L; Rowntree, Louise C; Nguyen, Thi H O; Hensen, Luca; Kedzierski, Lukasz; Cheng, Allen C; Kedzierska, Katherine; Au, Gough G; Marsh, Glenn A; Vasan, Seshadri S; Foo, Chwan Hong; Cowled, Christopher; Stewart, Cameron R.
  • Farr RJ; CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.
  • Rootes CL; CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.
  • Rowntree LC; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Nguyen THO; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Hensen L; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Kedzierski L; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Cheng AC; Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.
  • Kedzierska K; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Au GG; Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, Victoria, Australia.
  • Marsh GA; Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Vasan SS; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan.
  • Foo CH; CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.
  • Cowled C; CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.
  • Stewart CR; CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.
PLoS Pathog ; 17(7): e1009759, 2021 07.
Article in English | MEDLINE | ID: covidwho-1329138
ABSTRACT
The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 infection, however, remains poorly defined. Here we profiled circulating miRNAs from ten COVID-19 patients sampled longitudinally and ten age and gender matched healthy donors. We observed 55 miRNAs that were altered in COVID-19 patients during early-stage disease, with the inflammatory miR-31-5p the most strongly upregulated. Supervised machine learning analysis revealed that a three-miRNA signature (miR-423-5p, miR-23a-3p and miR-195-5p) independently classified COVID-19 cases with an accuracy of 99.9%. In a ferret COVID-19 model, the three-miRNA signature again detected SARS-CoV-2 infection with 99.7% accuracy, and distinguished SARS-CoV-2 infection from influenza A (H1N1) infection and healthy controls with 95% accuracy. Distinct miRNA profiles were also observed in COVID-19 patients requiring oxygenation. This study demonstrates that SARS-CoV-2 infection induces a robust host miRNA response that could improve COVID-19 detection and patient management.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: MicroRNAs / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: English Journal: PLoS Pathog Year: 2021 Document Type: Article Affiliation country: Journal.ppat.1009759

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: MicroRNAs / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: English Journal: PLoS Pathog Year: 2021 Document Type: Article Affiliation country: Journal.ppat.1009759